Rapidly Hiring. They have a proprietary drug delivery platform known as the Technosphere. They deliver drugs through the lungs instead of injection or pills.
Afrezza their FDA approved drug is finally starting to generate sales after being fda approved years ago.
They are also working on several other products for 2020.
Huge accumulation range and due to very aggressive short sellers flooding the market with over 40 million additional shares over the years.
All of these short sales will eventually be pressured to rebuy rapidly driving up price. There are also warrants that were delayed and expire in July.
With the healthcare sector and biotech improving at a rapid pace, an effective product, all the catalysts are there.
Afrezza their FDA approved drug is finally starting to generate sales after being fda approved years ago.
They are also working on several other products for 2020.
Huge accumulation range and due to very aggressive short sellers flooding the market with over 40 million additional shares over the years.
All of these short sales will eventually be pressured to rebuy rapidly driving up price. There are also warrants that were delayed and expire in July.
With the healthcare sector and biotech improving at a rapid pace, an effective product, all the catalysts are there.
Nota
Target is still $8Nota
$10Nota
Update to $20
Penerbitan berkaitan
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penerbitan berkaitan
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.